| T0 | T1 Baseline (lab) | T2 4 weeks (postal) | T3 8 weeks (postal) | T4 12 weeks (lab) |
---|---|---|---|---|---|
Postal invitation | X | Â | Â | Â | Â |
Telephone screening | X | Â | Â | Â | Â |
Informed consent | Â | X | Â | Â | Â |
Baseline assessments | |||||
 Medical history questionnaires |  | X |  |  |  |
 3D foot scanning |  | X |  |  | X |
 Biomechanical assessment |  | X |  |  |  |
 Randomisation |  | X |  |  |  |
 Receive intervention |  | X |  |  |  |
 CEQ |  | X |  |  |  |
 MOS (intervention group only) |  | X |  |  | X |
Outcome measures | |||||
 MOXFQ |  | X | X | X | X |
 Muscle strength |  | X |  |  | X |
 SF-12 |  | X | X | X | X |
 Use of cointerventions |  | X | X | X | X |
 Incidental and planned activity questionnaire |  | X | X | X | X |
 Perception of overall treatment effect |  |  | X | X | X |
Adherence | |||||
 Footwear/orthoses |  | continuous (Orthotimer®) | |||
 Exercise |  | continuous (PhysiTrack® app) | |||
 Adverse events |  | X | X | X | X |